These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 28290464)

  • 1. Blocking the recruitment of naive CD4
    Su S; Liao J; Liu J; Huang D; He C; Chen F; Yang L; Wu W; Chen J; Lin L; Zeng Y; Ouyang N; Cui X; Yao H; Su F; Huang JD; Lieberman J; Liu Q; Song E
    Cell Res; 2017 Apr; 27(4):461-482. PubMed ID: 28290464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression.
    Sun Z; Du C; Xu P; Miao C
    J Cell Physiol; 2019 Apr; 234(4):4608-4616. PubMed ID: 30216450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
    Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
    Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.
    Xu L; Xu W; Qiu S; Xiong S
    Clin Immunol; 2010 Jun; 135(3):466-75. PubMed ID: 20181533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
    Zhu S; Lin J; Qiao G; Xu Y; Zou H
    Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of CCL18 antagonist blocking breast cancer metastasis.
    Liu Y; Zheng H; Li Q; Li S; Lai H; Song E; Li D; Chen J
    Clin Exp Metastasis; 2019 Jun; 36(3):243-255. PubMed ID: 31062206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific recruitment of γδ regulatory T cells in human breast cancer.
    Ye J; Ma C; Wang F; Hsueh EC; Toth K; Huang Y; Mo W; Liu S; Han B; Varvares MA; Hoft DF; Peng G
    Cancer Res; 2013 Oct; 73(20):6137-48. PubMed ID: 23959855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4
    Liu S; Tao Z; Lou J; Li R; Fu X; Xu J; Wang T; Zhang L; Shang W; Mao Y; Wang F
    J Transl Med; 2023 Nov; 21(1):803. PubMed ID: 37950246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor-infiltrating CCR8
    Chen Q; Shen M; Yan M; Han X; Mu S; Li Y; Li L; Wang Y; Li S; Li T; Wang Y; Wang W; Wei Z; Hu C; Jin A
    J Transl Med; 2024 Jul; 22(1):709. PubMed ID: 39080766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
    Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
    Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
    Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
    Taylor NA; Vick SC; Iglesia MD; Brickey WJ; Midkiff BR; McKinnon KP; Reisdorf S; Anders CK; Carey LA; Parker JS; Perou CM; Vincent BG; Serody JS
    J Clin Invest; 2017 Sep; 127(9):3472-3483. PubMed ID: 28825599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
    Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
    Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary CCL18 recruits human regulatory T cells.
    Chenivesse C; Chang Y; Azzaoui I; Ait Yahia S; Morales O; Plé C; Foussat A; Tonnel AB; Delhem N; Yssel H; Vorng H; Wallaert B; Tsicopoulos A
    J Immunol; 2012 Jul; 189(1):128-37. PubMed ID: 22649201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.
    Huang Y; Ma C; Zhang Q; Ye J; Wang F; Zhang Y; Hunborg P; Varvares MA; Hoft DF; Hsueh EC; Peng G
    Oncotarget; 2015 Jul; 6(19):17462-78. PubMed ID: 25968569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL18 in the Progression of Cancer.
    Korbecki J; Olbromski M; Dzięgiel P
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection.
    Wang B; Xu D; Yu X; Ding T; Rao H; Zhan Y; Zheng L; Li L
    Ann Surg Oncol; 2011 Sep; 18(9):2585-93. PubMed ID: 21347781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages promote intratumoral conversion of conventional CD4
    Kos K; Salvagno C; Wellenstein MD; Aslam MA; Meijer DA; Hau CS; Vrijland K; Kaldenbach D; Raeven EAM; Schmittnaegel M; Ries CH; de Visser KE
    Oncoimmunology; 2022; 11(1):2063225. PubMed ID: 35481289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
    Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R
    Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.